Gamma-Aminobutyric Acid

Análisis de coste-efectividad en el tratamiento farmacológico del síndrome de fibromialgia en México

Treatment Outcome / Mexico / Humans / Markov chains / Amines / Fibromyalgia / Tramadol / FLUOXETINE / Economic Models / Cost Benefit Analysis / Drug Costs / Combination drug therapy / MEXICO / Acetaminophen / Analgesics / Amitriptyline / Reumatología / Gamma-Aminobutyric Acid / Fibromyalgia / Tramadol / FLUOXETINE / Economic Models / Cost Benefit Analysis / Drug Costs / Combination drug therapy / MEXICO / Acetaminophen / Analgesics / Amitriptyline / Reumatología / Gamma-Aminobutyric Acid